-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will...
More »SEARCH RESULT
Total Matching Records found : 4195
A liability for our nuclear plans -MR Srinivasan
-The Hindu In the context of the ongoing debate on Kudankulam, the question of nuclear liability has come to the fore again. As a person who engaged with this question almost 50 years ago, I would like to throw some light on the subject. As a lead member of the Indian team negotiating the Tarapur contract with the Americans, it fell to my remit to address this matter. General Electric and...
More »True Progressivism
-The Economist A new form of radical centrist politics is needed to tackle inequality without hurting economic growth BY THE end of the 19th century, the first age of globalisation and a spate of new inventions had transformed the world economy. But the “Gilded Age” was also a famously unequal one, with America’s robber barons and Europe’s “Downton Abbey” classes amassing huge wealth: the concept of “conspicuous consumption” dates back to 1899....
More »Cabinet clears way for direct transfer of fertilizer subsidy-Surabhi Agarwal, Aman Malik and Liz Mathew
-Live Mint Step is another sign of government intent to move towards direct transfer for all programmes The Union cabinet on Thursday approved a proposal that will eventually lead to the direct transfer of cash subsidies to farmers for fertilizer, two weeks after it put in place the architecture to enable such a transition. The step is another sign of the government’s intent to move towards a regime of direct transfer of cash...
More »SC gives govt time till Nov 27 for final drug pricing policy -Utkarsh Anand
-The Indian Express The Supreme Court on Thursday gave one month’s time to the Centre to come up with the final version of the drug pricing policy. Maintaining that the Centre must follow a pricing formula that will prevent the prices of the drugs from shooting up, the SC agreed to wait till mid-November for the Cabinet to come up with its final version of the new pricing policy. “Drugs prescribed by doctors......
More »
